Raymond James Financial Inc. Takes Position in Henry Schein, Inc. (NASDAQ:HSIC)

Raymond James Financial Inc. purchased a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 501,734 shares of the company's stock, valued at approximately $34,720,000. Raymond James Financial Inc. owned approximately 0.40% of Henry Schein as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. ING Groep NV purchased a new position in Henry Schein during the third quarter valued at $63,226,000. Holocene Advisors LP purchased a new position in Henry Schein during the 3rd quarter valued at about $58,319,000. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Henry Schein during the third quarter worth about $43,740,000. Southpoint Capital Advisors LP boosted its stake in Henry Schein by 30.0% during the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock worth $189,540,000 after acquiring an additional 600,000 shares in the last quarter. Finally, Bank of Montreal Can grew its holdings in Henry Schein by 365.6% in the third quarter. Bank of Montreal Can now owns 711,487 shares of the company's stock worth $52,095,000 after purchasing an additional 558,689 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Performance

HSIC traded up $1.22 during midday trading on Monday, hitting $71.80. 2,009,568 shares of the company traded hands, compared to its average volume of 1,505,096. The company's 50-day moving average is $74.84 and its 200 day moving average is $72.62. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $8.92 billion, a PE ratio of 29.55, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49.

Remove Ads

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter last year, the company earned $0.66 EPS. The firm's revenue for the quarter was up 5.8% on a year-over-year basis. On average, research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Jefferies Financial Group boosted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. UBS Group dropped their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target for the company. Barrington Research reiterated an "outperform" rating and issued a $90.00 price target on shares of Henry Schein in a research note on Wednesday, February 26th. Finally, Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price objective on the stock. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Henry Schein has a consensus rating of "Moderate Buy" and a consensus target price of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.